| Stage | HLX | % of rev | UFCS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $304M | 100.00% | $384M | 100.00% | UFCS ×1.26 |
| Gross profit | $56M | 18.49% | $383M | 99.71% | UFCS +81.2pp |
| Operating income | $27M | 8.79% | $46M | 11.86% | UFCS +3.1pp |
| Pre-tax income | $22M | 7.37% | $42M | 10.92% | UFCS +3.5pp |
| Net income | $23M | 7.47% | $33M | 8.69% | UFCS +1.2pp |
| Stage | HLX | UFCS | Gap · A − B |
|---|---|---|---|
| Revenue | $304M100.00% | $384M100.00% | UFCS ×1.26 |
| Gross profit | 18.49%$56M | 99.71%$383M | UFCS +81.2pp |
| Operating income | 8.79%$27M | 11.86%$46M | UFCS +3.1pp |
| Pre-tax income | 7.37%$22M | 10.92%$42M | UFCS +3.5pp |
| Net income |
| 7.47%$23M |
| 8.69%$33M |
| UFCS +1.2pp |
No shared counterparties.